OlivePoint Capital and Redwood Capital Management Secure Prime Research Triangle Park Office Asset
LOS ANGELES – In a move signaling a contrarian stance on the currently embattled office sector, OlivePoint Capital, a real estate investment manager specializing in thematic and special situations, has partnered with Redwood Capital Management, an alternative investment manager with a focus on opportunistic credit, to acquire 3900 Paramount Parkway. The 220,000-square-foot Class A office building is strategically located within Research Triangle Park (RTP) in Raleigh-Durham, a region recognized as one of the nation’s most dynamic innovation corridors.
The transaction highlights a significant acquisition at a time when broader market sentiment towards office properties remains subdued. This specific asset, however, presents a compelling case for investors willing to look beyond the headlines.
The property is fully leased to Pharmaceutical Product Development (PPD), a subsidiary of Thermo Fisher Scientific. As a critical component of a global life sciences leader with a strong investment-grade credit rating, PPD’s long-term lease agreement and the corporate guarantee from Thermo Fisher Scientific provide a stable and predictable cash flow stream.
**A Data-Driven Approach to a Market in Flux**
OlivePoint Capital emphasizes a data-driven, thematic investment approach, identifying opportunities where market dislocations create mispriced quality assets. The acquisition of 3900 Paramount Parkway, reportedly at a considerable discount to both replacement cost and current market valuations for similar properties, aligns with this strategy.
“The prevailing negative narratives surrounding the office market have created a disconnect between asset pricing and fundamental value,” noted Adrian Bejarano, Co-Founder & Managing Partner at OlivePoint Capital. “Our focus is on discerning genuine value amidst market noise. In specific submarkets, where strong credit, prime locations, and favorable replacement costs converge, the current environment offers substantial return potential. Paramount Parkway exemplifies an institutional-quality asset that has been inadvertently overlooked during a general market downturn.”
Ruben Kliksberg and Sean Sauler, Co-CIOs at Redwood Capital Management, shared this perspective: “We are enthusiastic about our collaboration with OlivePoint on the 3900 Paramount Parkway investment. The property’s robust cash-flow generation, underpinned by a high-caliber tenant, and its strategic placement within a burgeoning market, perfectly align with our objective of identifying undervalued risks and special situations that offer attractive risk-adjusted returns, particularly in a capital-constrained environment.”
**The Strategic Advantage of Raleigh-Durham**
Research Triangle Park is a globally recognized hub for scientific innovation, hosting over 375 companies spanning biotechnology, pharmaceuticals, technology, and advanced manufacturing. The Raleigh-Durham metropolitan area consistently ranks among the top national markets for sustained population and income growth, attracting leading global enterprises and a highly skilled workforce.
“RTP stands out as one of the few ecosystems where tenant demand is driven by mission-critical research, engineering, and life sciences endeavors,” commented John Bruno, Partner at OlivePoint Capital. “We anticipate that continued growth and innovation within this region will further solidify the long-term value of well-positioned assets like Paramount Parkway.”
**A Strategy Forged in Market Dislocation**
This acquisition underscores OlivePoint Capital’s Office Special Situations Strategy, which is specifically designed to capitalize on periods of market turbulence. The strategy targets assets offering durable, credit-backed cash flows, strategic geographical positioning, and inherent downside protection, particularly when capital market pressures lead to distressed selling opportunities.
“Our team possesses extensive experience navigating complex and evolving market cycles,” Bruno added. “Historically, periods of dislocation have proven to be some of the most opportune times to deploy capital. We are committed to investing where we identify fundamental value, guided by rigorous data analysis rather than market sentiment.”
**About OlivePoint Capital**
OlivePoint Capital is a Los Angeles-based investment manager dedicated to identifying special situation and thematic opportunities within the U.S. real estate market, with a particular focus on the lower-middle market. The firm leverages institutional-grade expertise and hands-on execution to uncover opportunities often overlooked by conventional investment strategies. OlivePoint Capital manages assets on behalf of a diverse range of institutional investors, including pension funds, fund-of-funds, and family offices.
Original article, Author: Jam. If you wish to reprint this article, please indicate the source:https://aicnbc.com/14551.html
